Synthesis of 30 grams of the target compound, task order period of performance: 2/28/2018-4/27/2018.

Ended Awarded Last action

Contract number
HHSN26100002
Awardee
Awarding agency
Obligated
$42,001

Award facts

Opportunity
Contract value 100% obligated
$42,000.62 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
B599 Special Studies/Analysis- Other
Set-aside
No set-aside
Competition
Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Santa Fe, FL 32615, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00001 · Synthesis of 30 grams of the target compound. Task order HHSN26100002 to period of performance: 2/28/2018-4/27/2018. -$11
Original award $42,012

Quick answers

Who was awarded contract HHSN26100002?

HHSN26100002 was awarded to Alchem Laboratories Corporation by National Cancer Institute (National Institutes of Health) on February 28, 2018.

How much is contract HHSN26100002 worth?

The government has obligated $42,001 on HHSN26100002.

Is contract HHSN26100002 an order under another contract?

Yes. HHSN26100002 is a delivery order under HHSN261201700007I, an indefinite delivery contract.

Was contract HHSN26100002 competed?

The extent of competition for HHSN26100002 was full and open competition after exclusion of sources.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award